EGF is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

Is SYN-AKE FDA approved?

SYN-AKE is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

How is EGF administered in research settings?

In research settings, EGF is typically administered via the topical, subcutaneous, or microneedling routes. PeptideBase does not provide dosing or administration instructions.

How is SYN-AKE administered in research settings?

In research settings, SYN-AKE is typically administered via the topical route. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›EGF vs SYN-AKE

Peptide Comparison

EGF vs SYN-AKE

Q: What is the difference between EGF and SYN-AKE?

EGF: Binds EGFR (EGF receptor / ErbB1), activating RAS/MAPK and PI3K/Akt signaling cascades. SYN-AKE: Reversibly antagonizes nicotinic acetylcholine receptors (nAChR) at neuromuscular junctions in facial skin, reducing involuntary muscle microcontractions. Effect is topical, localized, and fully reversible.

Both are Skin & Cosmetic peptides.

EGF

Epidermal Growth Factor

Skin & JointNot EvaluatedResearch Only

No providers listed yet

Full EGF profile →

SYN-AKE

Dipeptide Diaminobutyroyl Benzylamide Diacetate

Skin & JointNot EvaluatedResearch Only

No providers listed yet

Full SYN-AKE profile →

Bottom line

EGF has published research citations on file; SYN-AKE does not yet — the main evidence gap between them.

Quick Verdict

EGF

SYN-AKE

Which One Should You Choose?

Your goal	Better option
Has published research citations	EGF

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

EGF

SYN-AKE

Mechanism Family

Skin & Cosmetic

Half-life

—

FDA Status

not evaluated

Admin Routes

topical, subcutaneous, microneedling

topical

Availability

Research Only

Providers

None listed

Research Evidence

EGF

Review · 2 key studies · most recent 2026

SYN-AKE

No citations on file

Research Citations

EGF

In vitro2026 · Gels

Development of Antiseptic and Epidermal Growth Factor Co-Loaded Thermoresponsive Composite Hydrogel for Wound…

Review2026 · Cell Tissue Bank

Determinants of extraction efficiency in human amniotic membrane processing: biological, mechanical, and bioc…

SYN-AKE

No citations on file.

About EGF

Binds EGFR (EGF receptor / ErbB1), activating RAS/MAPK and PI3K/Akt signaling cascades. Promotes keratinocyte and fibroblast proliferation, accelerates wound re-epithelialization, and stimulates collagen and hyaluronic acid production.

Research Areas

skin regenerationwound healingcollagen stimulationpost-procedure recovery

About SYN-AKE

Reversibly antagonizes nicotinic acetylcholine receptors (nAChR) at neuromuscular junctions in facial skin, reducing involuntary muscle microcontractions. Effect is topical, localized, and fully reversible.

Research Areas

wrinkle reductionexpression line softeningmuscle relaxationanti-aging

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

EGF

Absolute Contraindications

Under clinical review

Being verified by our medical team before we display contraindications for this peptide.

SYN-AKE

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Find Providers

Where to source these peptides

Providers offering

EGF

Browse directory →

Providers offering

SYN-AKE

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Skin & Cosmetic Comparisons

Browse all peptides →

Educational research tools — not medical advice.